Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125230131 | 12523013 | 1 | I | 201502 | 20160621 | 20160701 | 20160701 | EXP | CH-TEVA-672452ISR | TEVA | 39.00 | YR | M | Y | 76.00000 | KG | 20160702 | MD | CH | CH |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125230131 | 12523013 | 1 | I | Nopil forte Tabletten | SULFAMETHOXAZOLETRIMETHOPRIM | 1 | Unknown | 0 | 1 | DF | TIW | ||||||||
| 125230131 | 12523013 | 2 | PS | CITALOPRAM | CITALOPRAM HYDROBROMIDE | 1 | Unknown | 20 MILLIGRAM DAILY; 1 DF IN THE MORNING | 77232 | 20 | MG | QD | |||||||
| 125230131 | 12523013 | 3 | SS | VFEND | VORICONAZOLE | 1 | Unknown | 400 MILLIGRAM DAILY; 1 DF IN THE MORNING AND 1 DF IN THE EVENING | Y | 0 | 200 | MG | FILM-COATED TABLET | BID | |||||
| 125230131 | 12523013 | 4 | SS | VFEND | VORICONAZOLE | 1 | Unknown | Y | 0 | 300 | MG | FILM-COATED TABLET | BID | ||||||
| 125230131 | 12523013 | 5 | SS | VFEND | VORICONAZOLE | 1 | Unknown | 400 MILLIGRAM DAILY; 1 DF IN THE MORNING AND 1 DF IN THE EVENING | Y | 0 | 200 | MG | FILM-COATED TABLET | BID | |||||
| 125230131 | 12523013 | 6 | SS | VALTREX | VALACYCLOVIR HYDROCHLORIDE | 1 | Unknown | 1000 MILLIGRAM DAILY; 1 DF IN THE MORNING AND 1 DF IN THE EVENING | 0 | 500 | MG | FILM-COATED TABLET | BID | ||||||
| 125230131 | 12523013 | 7 | SS | PANTOZOL | PANTOPRAZOLE SODIUM | 1 | Unknown | 40 MILLIGRAM DAILY; 1 DF IN THE MORNING | 0 | 40 | MG | TABLET | QD | ||||||
| 125230131 | 12523013 | 8 | SS | Ciproxin | CIPROFLOXACIN | 1 | Unknown | 0 | |||||||||||
| 125230131 | 12523013 | 9 | SS | NEXAVAR | SORAFENIB | 1 | Unknown | 800 MILLIGRAM DAILY; STRENGH 200 MG, 2 DF IN THE MORNING AND 2 DF IN THE EVENING | 0 | 400 | MG | TABLET | BID | ||||||
| 125230131 | 12523013 | 10 | C | Prednison | PREDNISONE | 1 | Unknown | 10 MILLIGRAM DAILY; | U | 0 | 10 | MG | QD | ||||||
| 125230131 | 12523013 | 11 | C | Sandimmun | CYCLOSPORINE | 1 | Unknown | 75 MILLIGRAM DAILY; STRENGTH 50 MG, 1 DF IN THE MORNING AND 0.5 DF IN THE EVENING | U | 0 | CAPSULE | ||||||||
| 125230131 | 12523013 | 12 | C | VITAMIN D3 | CHOLECALCIFEROL | 1 | Unknown | 4 GTT DAILY; STRENGTH UNSPECIFIED, 4 DROPS IN THE MORNING, SINCE APPROX. MAY-2015 | U | 0 | 4 | GTT | QD | ||||||
| 125230131 | 12523013 | 13 | C | Magnesiocard | MAGNESIUM ASPARTATE HYDROCHLORIDE | 1 | Unknown | 30 MILLIMOL DAILY; | U | 0 | 10 | MMOL | TID | ||||||
| 125230131 | 12523013 | 14 | C | Supradyn | ASCORBIC ACIDMINERALSVITAMINS | 1 | Unknown | 1 DOSAGE FORMS DAILY; | U | 0 | 1 | DF | QD | ||||||
| 125230131 | 12523013 | 15 | C | DAFALGAN | ACETAMINOPHEN | 1 | Unknown | 1500 MILLIGRAM DAILY; | U | 0 | 500 | MG | TABLET | TID | |||||
| 125230131 | 12523013 | 16 | C | AUGMENTIN | AMOXICILLINCLAVULANATE POTASSIUM | 1 | Unknown | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125230131 | 12523013 | 8 | Antibiotic prophylaxis |
| 125230131 | 12523013 | 16 | Antibiotic prophylaxis |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125230131 | 12523013 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125230131 | 12523013 | Drug interaction | |
| 125230131 | 12523013 | Drug level increased | |
| 125230131 | 12523013 | Dysarthria | |
| 125230131 | 12523013 | Graft versus host disease in skin | |
| 125230131 | 12523013 | Infection | |
| 125230131 | 12523013 | Photosensitivity reaction | |
| 125230131 | 12523013 | Rash |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125230131 | 12523013 | 1 | 201501 | 0 | ||
| 125230131 | 12523013 | 2 | 201505 | 0 | ||
| 125230131 | 12523013 | 3 | 20150821 | 20150904 | 0 | |
| 125230131 | 12523013 | 4 | 20150715 | 20150820 | 0 | |
| 125230131 | 12523013 | 5 | 20150516 | 20150714 | 0 | |
| 125230131 | 12523013 | 6 | 201501 | 0 | ||
| 125230131 | 12523013 | 7 | 201501 | 0 | ||
| 125230131 | 12523013 | 8 | 20150821 | 0 | ||
| 125230131 | 12523013 | 9 | 20150324 | 0 | ||
| 125230131 | 12523013 | 10 | 201505 | 0 | ||
| 125230131 | 12523013 | 11 | 201504 | 0 | ||
| 125230131 | 12523013 | 12 | 201505 | 0 | ||
| 125230131 | 12523013 | 13 | 201505 | 0 | ||
| 125230131 | 12523013 | 14 | 201501 | 0 | ||
| 125230131 | 12523013 | 16 | 20150821 | 0 |